On June 21, 2022, AbbVie Inc. (NYSE: ABBV) opened at $139.95, higher 3.75% from the last session. During the day, the shares moved up to $143.965 and dropped to $139.70 before settling in for the closing price of $138.28. Price fluctuations for ABBV have ranged from $105.56 to $175.91 over the past 52 weeks.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Healthcare Sector giant saw their annual sales surged by 17.00% over the last five years. Company’s average yearly earnings per share was noted 137.00% at the time writing. With a float of $1.77 billion, this company’s outstanding shares have now reached $1.77 billion.
The firm has a total of 50000 workers. Let’s measure their productivity. In terms of profitability, gross margin is +69.49, operating margin of +35.14, and the pretax margin is +23.11.
AbbVie Inc. (ABBV) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of AbbVie Inc. is 0.10%, while institutional ownership is 70.90%. The most recent insider transaction that took place on May 23, was worth 12,041,780. In this transaction Vice Chairman of this company sold 79,801 shares at a rate of $150.90, taking the stock ownership to the 152,103 shares. Before that another transaction happened on May 17, when Company’s Vice Chairman sold 100,000 for $154.04, making the entire transaction worth $15,404,400. This insider now owns 152,103 shares in total.
AbbVie Inc. (ABBV) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted $3.16 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $3.14) by $0.02. This company achieved a net margin of +20.41 while generating a return on equity of 80.52. Wall Street market experts anticipate that the next fiscal year will bring earnings of 3.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 137.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.87% during the next five years compared to 12.20% growth over the previous five years of trading.
AbbVie Inc. (NYSE: ABBV) Trading Performance Indicators
Check out the current performance indicators for AbbVie Inc. (ABBV). In the past quarter, the stock posted a quick ratio of 0.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.50. Likewise, its price to free cash flow for the trailing twelve months is 20.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.97, a number that is poised to hit 3.43 in the next quarter and is forecasted to reach 11.90 in one year’s time.
Technical Analysis of AbbVie Inc. (ABBV)
Analysing the last 5-days average volume posted by the [AbbVie Inc., ABBV], we can find that recorded value of 7.28 million was lower than the volume posted last year of 7.62 million. As of the previous 9 days, the stock’s Stochastic %D was 28.79%. Additionally, its Average True Range was 3.61.
During the past 100 days, AbbVie Inc.’s (ABBV) raw stochastic average was set at 24.31%, which indicates a significant decrease from 52.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 25.64% in the past 14 days, which was higher than the 24.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $151.63, while its 200-day Moving Average is $135.13. Now, the first resistance to watch is $145.06. This is followed by the second major resistance level at $146.64. The third major resistance level sits at $149.32. If the price goes on to break the first support level at $140.79, it is likely to go to the next support level at $138.11. Now, if the price goes above the second support level, the third support stands at $136.53.
AbbVie Inc. (NYSE: ABBV) Key Stats
There are currently 1,767,110K shares outstanding in the company with a market cap of 255.12 billion. Presently, the company’s annual sales total 56,197 M according to its annual income of 11,542 M. Last quarter, the company’s sales amounted to 13,538 M and its income totaled 4,490 M.